Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Souery, D.
418  Ergebnisse:
Personensuche X
?
1

Association between polygenic risk scores of subcortical br..:

Oliva, V. ; Martone, A. ; Fanelli, G....
Neuroscience Applied.  2 (2023)  - p. 102912 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Psychotherapy employed additionally to Psychopharmacotherap..:

Bartova, L. ; Fugger, G. ; Dold, M....
European Psychiatry.  65 (2022)  S1 - p. S73-S74 , 2022
Link: https://doi.org/10.1192/..
 
?
3

Genetic dissection of the clinical heterogeneity of major d..:

Oliva, V. ; Fanelli, G. ; Kasper, S....
Neuroscience Applied.  1 (2022)  - p. 100480 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Pharmacogenetics of CYP2C19 in response and side effects to..:

Calabrò, M. ; Fabbri, C. ; Kasper, S....
Neuroscience Applied.  1 (2022)  - p. 100482 , 2022
Link: https://doi.org/10.1016/..
 
?
5

P.0882 A meta-analysis of polygenic risk scores for mood di..:

Fanelli, G. ; Fabbri, C. ; Domschke, K....
European Neuropsychopharmacology.  53 (2021)  - p. S646-S647 , 2021
Link: https://doi.org/10.1016/..
 
?
6

P.335 Drug repositioning for treatment-resistant depression..:

Fabbri, C. ; Kasper, S. ; Zohar, J....
European Neuropsychopharmacology.  40 (2020)  - p. S195-S196 , 2020
Link: https://doi.org/10.1016/..
 
?
7

P.141 Topological data analysis for genetic-driven stratifi..:

Maggioni, E. ; Fabbri, C. ; Vai, B....
European Neuropsychopharmacology.  40 (2020)  - p. S86-S87 , 2020
Link: https://doi.org/10.1016/..
 
?
8

P.171 Higher polygenic risk scores for schizophrenia may be..:

Fanelli, G. ; Benedetti, F. ; Kasper, S....
European Neuropsychopharmacology.  40 (2020)  - p. S99-S100 , 2020
Link: https://doi.org/10.1016/..
 
?
9

P.179 Polygenic risk scores for multiple psychiatric, infla..:

Fanelli, G. ; Sokolowski, M. ; Wasserman, D....
European Neuropsychopharmacology.  40 (2020)  - p. S105-S106 , 2020
Link: https://doi.org/10.1016/..
 
?
10

P.057 A genetic predictor of treatment-resistant depression..:

Fabbri, C. ; Kasper, S. ; Kautzky, A....
European Neuropsychopharmacology.  29 (2019)  - p. S58-S59 , 2019
Link: https://doi.org/10.1016/..
 
?
11

A genome-wide association study of treatment-resistant depr..:

Fabbri, C. ; Kasper, S. ; Kautzky, A....
European Neuropsychopharmacology.  29 (2019)  - p. S364-S365 , 2019
Link: https://doi.org/10.1016/..
 
?
12

P.321 Clinical parameters associated with augmentation and ..:

Bartova, L. ; Dold, M. ; Mendlewicz, J....
European Neuropsychopharmacology.  29 (2019)  - p. S229-S230 , 2019
Link: https://doi.org/10.1016/..
 
?
13

P.021 Social dysfunction in mood disorders and schizophreni..:

Porcelli, S. ; Kasper, S. ; Zohar, J....
European Neuropsychopharmacology.  29 (2019)  - p. S34-S35 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Clinical predictors of treatment resistant depression: Repl..:

Kautzky, A. ; Dold, M. ; Bartova, L....
European Neuropsychopharmacology.  29 (2019)  - p. S61-S62 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Clinical factors predicting treatment resistant depression:..:

Kautzky, A. ; Dold, M. ; Bartova, L....
Acta Psychiatrica Scandinavica.  139 (2018)  1 - p. 78-88 , 2018
Link: https://doi.org/10.1111/..
 
1-15